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New Computational Protein Design Methods for De Novo
Small Molecule Binding Sites
James Edward Lucas
Abstract
Protein binding to small molecules is fundamental to many biological processes, yet it remains
challenging to predictively design this functionality de novo. Current state-of-the-art computational
design methods typically rely on existing small molecule binding sites or protein scaffolds with
existing shape complementarity for a target ligand. Here we introduce new methods that utilize
pools of discrete contacts observed in the Protein Data Bank between protein residues and defined
small molecule ligand substructures (ligand fragments). We use the Rosetta Molecular Modeling
Suite to recombine protein residues in these contact pools to generate hundreds of thousands of
energetically favorable binding sites for a target ligand. These composite binding sites are built
into existing scaffold proteins matching the intended binding site geometry with high accuracy.
In addition, we apply pools of rotamers interacting with the target ligand to augment Rosetta’s
conventional design machinery and improve key metrics known to be predictive of design success.
We demonstrate that our method reliably builds diverse binding sites into different scaffold proteins
for a variety of target molecules. Our generalizable de novo ligand binding site design method will
lay the foundation for versatile design of protein to interface previously unattainable molecules for
applications in medical diagnostics and synthetic biology.
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Chapter 1
Introduction
Proteins are macromolecules that perform the majority of life-sustaining functions within cells.
These functions are extremely diverse and include performing chemistry, sensing and respond-
ing to stimuli, transporting cargo, regulating transcription and translation of genetic material, and
providing structural support. Many of these processes rely on molecular recognition and bind-
ing of small molecules. However, despite comprehensive understanding of the physicochemical
properties that proteins use to mediate selective high-affinity interactions with small molecules,
current methods still lack the ability to predictively design cavities that impart binding function for
specific ligands. The ability to design proteins that bind to small molecules of interest is essential
to designing enzymes and sensors for a variety of applications. The work in this dissertation in
particular was originally motivated by the design of chemically-induced protein dimerization sys-
tems to couple sensing of arbitrary small molecule targets to a wide array of in vitro and in vivo
responses.
To this end, there has been extensive efforts to develop computational methods for protein
small molecule binding site design. The Rosetta Macromolecular Modeling Suite is one such com-
putational tool that has been successfully applied to model and impart a variety of protein struc-
tures and functions, including ligand binding. While there have been several successful methods
developed within Rosetta for designing small molecule binding sites, there are still several defi-
ciencies that need to be addressed before predictable design of small molecule binding sites can
become routine.
The work in this dissertation attempts to address several of these deficiencies by leveraging
1
empirical protein-ligand contact information from the Protein Data Bank to augment the design
capabilities of Rosetta. This work aims to develop a framework where binding site design can be
routinely performed for arbitrary small molecule targets.
2
Chapter 2
Computational Design Methods for De
Novo Small Molecule Binding Sites
2.1 Introduction
Despite significant advances in de novo design of protein structures, innovations in algorithms and
methodologies for the computational design of protein function have not kept pace.1,2 In particu-
lar, it remains challenging to design proteins that bind new small molecule ligands.3,4 The ability
to design proteins with high-affinity interactions for defined small molecule targets is important
for creating enzymes with novel substrates, receptors and transcription factors that sense and
respond to unique inducer molecules, and binders that can recognize and sequester arbitrary lig-
ands. On-demand design of proteins with defined small-molecule binding functionality would have
many applications in bioremediation, synthetic biology, and medical diagnostics.
Various strategies have been developed and successfully applied to the computational de-
sign of ligand binding function. For instance, design methods in the Rosetta Macromolecular
Modeling Suite5 have been used to reengineer proteins to bind digoxigenin,6 fentanyl,7 and 17a-
hydroxylprogesterone,3 to create a new binding site for the metabolic intermediate farnesyl py-
rophosphate in a protein-protein interface to build synthetic sense/response systems,8 and to
place a binding site for (Z)-4-(3,5- difluoro-4-hydroxybenzylidene)-1,2-dimethyl-1H-imidazol-5(4H)-
one (DFHBI) into the cavity of a de novo designed beta-barrel.9 There are several examples of de
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novo designed helical bundles that bind various ligands,10 including a recent synthetic porphyrin
binder that was engineered through simultaneous optimization of the binding site and a remote,
well-packed core.11 Another common avenue for designing binders with desired function is by
changing the ligand specificity of an existing binder, for example by grafting a binding site of a
close homolog.12
Common design protocols to introduce a new ligand binding function into a protein13 begin
with the specification of the binding site, where amino acid side chains and conformations are
geometrically defined to make key interactions with the target ligand. These binding site definitions
are typically derived based on chemical intuition or taken from an existing protein in complex with
the target ligand present in the Protein Data Bank (PDB). In a second step, the target ligand and
its defined contacts are placed into a new protein (termed "scaffold") using geometric matching,
such as the RosettaMatch application.14 Given a set of geometric constraints defining side chain
interactions with a target ligand, RosettaMatch attempts to find backbone positions in a scaffold
protein where side chains can be placed to satisfy all protein-ligand contact constraints and places
the ligand within the protein subject to these constraints. In a third step, sequence positions
surrounding any successfully matched binding site are redesigned to accommodate the newly
introduced ligand and defined side chains. The resulting design models are ranked based on
predicted protein stability and interaction energy with the ligand, in addition to a range of design
filters, and predictions are selected to be experimentally validated.
Despite previously demonstrated success of these protocols,6,8 there are still several limitations
that prevent generalizable de novo design of ligand binding sites. First, binding site geometries
need to be predefined for a target ligand. Even when binding site definitions can be derived from
existing complexes for the target ligand in the PDB, there may only be a few examples (if any) and
these might be limited to low-affinity binding interactions. Second, geometric matching algorithms
are typically only capable of incorporating binding site definitions composed of 3-5 residues due
to the complexity of finding backbone geometries in scaffold proteins that satisfy all user-defined
constraints. To find solutions, it is necessary to relax these constraints at the expense of deviat-
ing significantly from the geometries in the binding site definition. Third, binding site definitions
matched into a scaffold protein only constitute a part of the binding site and the remainder of the
binding site environment needs to be optimized through algorithms that change sequence identity
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(design) or side chain conformations (rotamer packing).15,16 Common binding site design meth-
ods such as those implemented in Rosetta, including the recently developed Rotamer Interaction
Field,9 rely on Rosetta’s energy function to introduce favorable interactions with the ligand. How-
ever, limitations in the energy function used for design may fail to capture important interactions
with the target ligand, such as pi-cation and pi-pi interactions17 or interactions with atom types
that are commonly encountered in ligands but less well parameterized.18 Finally, filtering steps
after design typically eliminate a majority of design candidates because they possess poor shape
complementarity, ligand burial, hydrogen bond satisfaction, and other metrics that are predictive
of success.
Here we describe a new approach that uses protein-ligand contact observations in the PDB
to address current shortcomings in defining and designing ligand binding sites. Our approach
generates hundreds of thousands of new binding site definitions in an automated fashion for ar-
bitrary target ligand conformations, regardless of whether a complete binding site definition can
be derived from an existing complex in the PDB. These binding site definitions yield thousands
of RosettaMatch solutions that agree well with originally defined geometries. We also introduce a
new design method that recapitulates key interactions in ligand binding sites. Moreover, we show
that the new design method improves several metrics in design that are predictive of success
when designs are experimentally characterized. While we have incorporated these new meth-
ods in Rosetta, the principles are generally applicable to other design approaches. The methods
introduced here will have broad utility to design binders for arbitrary small molecules, towards
predictable design of small molecule sensors, inducible transcription factors, and other functional
proteins.
2.2 Results
We sought to leverage the wealth of information in the PDB to address current shortcomings in
existing protein-ligand interface design methods. While high-affinity protein-ligand complexes for
small molecules of interest may be sparse or non-existent, our approach is built on the following:
(i) Target ligands are decomposed into substructures for which there are many contacts in the PDB
(Figure 2.1 panel A), and (ii) these observed contacts with each ligand-derived substructure are
5
Figure 2.1: Protocol Overview. A. Target small molecules are decomposed into fragments (high-
lighted red, orange, and blue) that are present as a substructure in a wide range of molecules
bound to proteins in the PDB. B. Protein complexes bound to substructure-containing molecules
are systematically parsed to generate contact pools representing all contact modes with each frag-
ment present in the PDB. These contacts are mapped onto the full target ligand (here ibuprofen) to
create a conformer-specific contact pool for downstream steps. C. A simulated annealing protocol
is used to assemble hundreds of thousands of three-residue composite binding sites from a target
ligand contact pool. RosettaMatch is then used to find scaffold proteins that can geometrically
accommodate a composite binding site solution. D. Sequence design is performed by Rosetta’s
design machinery, where positions in the protein can be set to designable (yellow bars) or not
designable (grey bars). Contact pools are used to supplement the set of rotamers generated by
Rosetta for designable positions. Rotamers are built in the context of a potential ligand interface
and any rotamers (purple sticks, pink spheres) that recapitulate an interaction in the contact pool
(gold lines, orange spheres) are added to the standard RotamerSet (green) and provided a score
bonus with the special_rot score term.
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used to assemble a pool of contacts for the target ligand (Figure 2.1 panel B).
We reasoned that these contact pools should improve design of new ligand binding sites in
three principal ways. First, reassembling "composite" binding sites by recombining protein-ligand
substructure contacts should provide an automated method to generate a large number of poten-
tial binding site definitions (even for ligands for which no complete binding site definition exists in
the PDB) that can be matched into scaffold proteins. Second, by dramatically increasing the num-
ber of binding site definitions used in the geometric matching step, we should increase the number
of scaffold protein "hits" that can accommodate these geometries well. Third, contact pools should
also be useful in the design step, by incorporating protein-ligand contacts that might otherwise be
missed in conventional design. As a result, we reasoned that design with contact pools should
increase key metrics such as protein-ligand shape complementarity in the design filtering step. To
test these ideas, we first apply the contact pools of protein-ligand interactions to assemble millions
of new binding site definitions that can be incorporated into protein scaffolds with RosettaMatch
(Figure 2.1 panel C). Second, we use contact pools to augment and inform existing design proto-
cols (Figure 2.1 panel D).19 In the following, we first describe the implementation of our protocol
to assemble contact pools. We then show that the application of contact pools to inform design
yields millions of strictly defined binding sites and improves key design metrics
2.2.1 Generation of contact pools
Our protocol produces a set of contact pools for an arbitrary number of potential ligand conformers
that can be applied to either A) generate binding site definitions that can be used as constraints
for the RosettaMatch application or B) generate rotamers to augment the conventional Rosetta
design machinery (i.e. the Packer).
We define a "fragment" as a ligand substructure constituting a distinct chemical moiety (Fig-
ure 2.1 panel A) that will form an interaction with a protein (Figure 2.1 panel B). Fragments are
composed of at least three atoms and are rigid substructures of the target ligand. While several
automated small molecule fragmentation methods exist, these methods typically break bonds for
retrosynthetic analysis in the context of fragment-based drug discovery.20,21 The assembly of con-
tact pools instead relies on the chemical intuition of the user to identify fragments that will mediate
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important interactions at the protein-ligand interface (e.g. hydrogen bond donors/acceptors, ring
systems) but are not necessarily segmented by breakable bonds.
2.2.2 The PDB is rich in protein-fragment contact information
To demonstrate the number and diversity of unique types of contacts that may be observed with
fragments in the PDB, we generated 34 fragments for a variety of chemical moieties that are found
in common drugs, toxins, and metabolites (Figure 2.2 panel A, Table 2.3). All protein-ligand
complexes in the PDB that contain these fragments were retrieved and transformed to superpose
the ligand substructure onto a reference fragment. Only protein side chain contacts within 4Å of the
ligand were kept. We defined a 16-dimensional feature vector for each protein residue encoding
the type of chemical contact mediated between the residue and the fragment (see Methods). We
then applied hierarchical agglomerative clustering to generate clusters of protein contacts within
the contact pool that we define to mediate unique "contact modes" (i.e. clusters) with each ligand
fragment.
Sorting clusters by occupancy revealed that fragments often possess a small number (<5%
of all clusters) of preferred, high-occupancy contact modes with remaining clusters consisting of
less prevalent contact modes (Figure 2.2 panel B). This observation suggests that proteins in the
PDB exhibit preferred modes of mediating interactions with the chemical environments that define
each fragment. Indeed, visually inspecting clusters with the highest occupancies for various frag-
ments revealed residue types mediating well-defined, favorable contact geometries that one would
expect. For instance, the most common contact modes with the adenine fragment (second row
from top) consist of bidentate hydrogen bonding interactions with the base mediated by side chain
functional groups (e.g. asparagine/glutamine carboxyamide) as well as backbone carbonyl/amine
functional groups (Figure 2.2 panel D).
The preference for a select number of contact modes led us to investigate what proportion of
the PDB would need to be sampled to recover a majority (>80%) of contact modes for each frag-
ment. To address this question, we bootstrapped 1000 random samples for different proportions of
the PDB and counted the number of unique contact modes recovered as defined by our previously
generated clusters. Only a minority fraction of the PDB (typically <40%) was required to recover
8
Figure 2.2: PDB sufficiently samples ligand-fragment contact space. A. Examples of fragment
definitions (highlighted in blue) and context as a substructure of a small molecule. B. Clusters for
each fragment are plotted in order of the number of members for each cluster ("contact mode").
Clusters to the left of the red vertical line represent the top 5% (high-occupancy) contact modes.
C. Average and standard deviation for the number of contact modes recovered at given fractions
of the PDB. D. Examples of high-occupancy clusters for fragments that illustrate expected favor-
able contact modes. White lines: clustered side chain contacts, teal: fragment carbons, orange:
phosphorous, yellow: sulfur, red: oxygen, blue: nitrogen. Hydrogen bonding contacts are depicted
as yellow dashed lines.
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at least 80% of unique contact modes with each fragment (Figure 2.2 panel C).
2.2.3 Using composite binding sites increases the number of high-quality matches
Our analysis of contact modes for ligand fragments in the PDB demonstrates the diversity of side
chain identities and geometries that proteins use to mediate interactions with unique chemical
moieties on the ligand. We next sought to use this diversity to expand the number of side chain
compositions and geometries that could be used to define a ligand binding site for methods like
RosettaMatch. Instead of using an existing binding site extracted from the PDB to define side chain
interactions with a target ligand, we used protein-fragment contacts to create "composite" binding
sites. We first fragmented the target ligand and generated a contact pool for each fragment using
discrete side chain-fragment interactions in the PDB. We then transformed the orientation of all
protein residues in each fragment contact pool relative to the source fragment in the target ligand to
preserve observed contact geometries (Figure 2.1 panel B). For the assembly of composite bind-
ing sites, we filtered these contacts using the fa_rep (Lennard-Jones, repulsive component), fa_atr
(Lennard-Jones, attractive component), fa_elec (coulombic electrostatic potential), hbond_sc (side
chain-side chain hydrogen bonds22), hbond_bb_sc (backbone-side chain hydrogen bonds), and
fa_sol (Lazaridis-Karplus solvation23) two-body terms in the Rosetta REF2015 all-atom energy
function.17 This additional filtering step yields a collection of residue contacts with the target ligand
that are not only observed in the PDB to interact with the target ligand, but are also determined to
be energetically favorable by Rosetta, to serve as "hot spot" residues for composite binding sites.24
These filtered pools contained on average 2,800 unique contacts for each ligand. This procedure
can be repeated for different ligand conformers generated using a conformer search tool such as
OpenEye Omega25 or RDKit.26
Given a contact pool for a ligand conformer, we applied a simulated annealing Monte Carlo
protocol similar to the Rosetta side chain rotamer optimization method (Packer) to yield low-energy
three-residue composite binding site solutions for the target ligand (Figure 2.1 panel D) (here we
illustrate the method with three-residue binding sites but larger sites could be used). Up to ten
trajectories are attempted for each contact pool and the best 100,000 three-residue binding sites
for each trajectory are recorded. The results from separate trajectories are consolidated and the
10
Figure 2.3: Discrete Protein-Fragment Contacts are Assembled into Composite Binding Sites. A.
Thousands of composite binding sites are generated by combining discrete, observed contacts
with fragments that compose the target ligand into low-energy configurations using a simulated
annealing protocol. B. RosettaMatch finds scaffold proteins with existing cavities that can accom-
modate the target ligand with close adherence to contact residue geometries defined in composite
binding site solutions (RosettaMatch residues: purple sticks, composite binding site definition: or-
ange lines). C. Comparison of protein residue (purple) interactions with defined fragments (yellow)
in the context of a protein-ligand complex that served as the source of a contact pool interaction
(Source) and in the context of a match produced using RosettaMatch and geometric constraints
derived from a composite binding site solution (Match). The source protein-ligand complex PDB
ID and ligand chemical component identifier are provided for each source interaction.
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Table 2.1: Numbers of matches found comparing complete binding sites extracted from the PDB
and composite binding sites generated by our method. Filtered match counts constitute the 25
best-scoring matches that pass quality filters for each set of matches that result from constraints
for a single composite binding site and place the same residue identities at the same positions in
a scaffold protein.
Complete Binding Sites From PDB Solved Constraints From Contact Pools
Chemical Component Identifier # Complete Binding Sites Raw Matches Filtered Matches # Constraints Raw Matches Filtered Matches
38E 2 2141 55 5000 2430929 31430
AFN 0 0 0 5000 1560062 27806
ATZ 1 0 0 5000 3797641 22525
DOG 4 3175 94 5000 578060 5041
IBP 12 1267 83 5000 1550018 16206
IM4 2 0 0 5000 3605143 49679
LFN 2 329 53 5000 4575191 38794
NPS 7 122 20 5000 2473723 18229
5,000 lowest-energy unique composite binding site solutions are used to generate constraints for
RosettaMatch.
Next, we used RosettaMatch to build composite binding sites into a monomer scaffold set
consisting of 401 proteins that had been previously applied to successfully redesign a protein
to bind a new ligand.6 We use stringent RosettaMatch constraints (see Methods) to ensure that
the match solutions found by RosettaMatch do not significantly deviate from defined constraint
geometries (Figure 2.3). We generated 5,000 composite binding sites for eight ligands (Table
2.4) and compared the number of matches found to those found using constraints generated from
existing binding sites for the corresponding ligands in the PDB. In every case, using composite
binding site solutions produces >50-fold more matches than conventional constraints derived from
existing protein-ligand complexes (Table 2.1). Only 5000 of the lowest-scoring composite binding
sites were used for this benchmark; many more potential match solutions can be found with the
hundreds of thousands of composite binding site solutions generated with this method. Moreover,
we find many more matches with composite binding sites that pass binding site energy, bump
check, and designability quality filters (see Methods, "filtered matches" in Table 1) than when using
PDB-derived constraints. Increasing the number of high-quality matches in this step is important
since they serve as starting points for design, and, frequently, even good matches do not yield
high-quality final design models because of difficulties generating good binding site environments
in the design step. We note that our method can generate composite binding sites and large
numbers of matches for ligands for which protein-ligand complexes are rare or do not exist in the
PDB (e.g. chemical component identifiers ATZ, AFN in Table 1).
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2.2.4 Complementary Rotamers Improve Binding Site Recapitulation
In addition to improving the numbers and quality of generated matches using composite binding
sites, we hypothesized that contact pools could also be used to improve the design step. Since
contact pools possess a wealth of information on how proteins in the PDB interact with different
chemical moieties present on ligands, we sought to incorporate this information into Rosetta’s core
design machinery (the Packer). We used the backbone-dependent Dunbrack library16 to generate
rotamers for protein positions at the ligand interface and added complementary rotamers that re-
capitulate interactions in the contact pool to the Packer RotamerSets (Figure 2.1 panel C). These
complementary rotamers were generated with additional χ-angle sampling for χ1 through χ4. For
each rotamer built at a position within a binding site, a set of three contact atoms were defined
based on contact geometry with the ligand. These atoms were compared to the same atoms for
the same residue identities in the contact pool. If rotamer contact atoms achieved an RMSD of
≤1.5Å with any residue in the contact pool, it was added to the set of complementary rotamers
for the current position. These additional rotamers are flagged as a "special_rot" variant.19 An
additional "special_rot" score term is enabled with a customizable bonus to bias incorporation of
empirically determined residue-ligand contacts during design.
To determine an appropriate value for the special_rot score bonus, we used a native sequence
recovery test15,27,28,29 on a panel of protein-ligand complexes. We identified a total of 22 protein-
ligand complexes from the BindingMOAD database30 and generated contact pools for each unique
ligand (Table 2.5) to create a set of empirically-determined rotamers to complement the rotamers
generated by the Packer. These "complementary rotamers" were included in 5000 design tra-
jectories for special_rot bonus values ranging from 0 (complementary rotamers are added to the
Packer but no score bonus is applied) to -10 Rosetta Energy Units (REUs). For each complex,
first and second shell contacts with the ligand as determined by the Rosetta Neighborhood and
ClashBasedRepackShell selectors (see Methods) were subjected to design. Profile similarity (see
Methods) and sequence recovery to the native complex sequence were calculated for designable
positions in the benchmark complexes to determine whether complementary rotamers improve
Rosetta’s ability to design the binding site environment, and if so, which special_rot score bonus
value was optimal. For the purposes of the native sequence recovery benchmark, a design posi-
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tion is considered recovered if >50% of designs incorporate the residue identity observed in the
original protein-ligand complex.
The application of complementary rotamers with the special_rot score term improves, or at
least matches, native sequence recovery over the unmodified Packer for special_rot bonus values
up to -4.0 REU in the benchmark set (Figure 2.4 panel A), with a special_rot bonus of -1.5 REU
providing optimal sequence recovery in this test. When considering the median profile similarity
for all 589 designable positions across the 22 complexes in our benchmark set as a metric, it
initially appears that the application of complementary rotamers do not provide a significant im-
provement to design (Figure 2.8). Median profile similarity remains constant with a special_rot
bonus between -0.5 and -4.0 REU, and is comparable to profiles generated using Rosetta’s un-
modified Packer as well as the addition of complementary rotamers without the application of the
special_rot score term. However, a significant fraction of designable positions achieved high pro-
file similarity (>0.9) regardless of modifications to the Packer. These positions were removed from
subsequent analysis to investigate the impact of complementary rotamers. With these positions
removed, it becomes evident that the addition of complementary rotamers can indeed provide a
modest improvement in median profile similarity above a special_rot bonus of -5.0 REU (Figure
2.4 panel B). As with sequence recovery, a special_rot bonus of -1.5 REU appears optimal for
median profile similarity in this test. Beyond a special_rot bonus of -4.0 REU, the addition of the
complementary rotamers becomes detrimental for both the native sequence recovery and profile
similarity metrics (Figure 2.4 panel A,B). This behavior is expected as the special_rot bonus be-
gins to outweigh penalties otherwise incurred due to unfavorable physical interactions (e.g. steric
clashes penalized by the repulsive score term fa_rep).
To investigate the per-position contributions of the complementary rotamers, we compared
position-specific profile similarities for all designable positions in our benchmark set for three spe-
cial_rot bonus values to results using the unmodified Packer (Figure 2.4 panel C). The addition of
complementary rotamers alone (with a special_rot bonus = 0) does not have a notable impact on
profile similarity, although two positions achieve >0.9 profile similarities with the complementary
rotamers while the unmodified Packer only achieves profile similarities <0.5 for the same positions
(Figure 2.4 panel C, left). The improvements provided by the complementary rotamers become
apparent with a special_rot bonus of -1.5 REU, where 56 of 589 design positions achieve >0.1
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Figure 2.4: Complementary Rotamers Improve Binding Site Sequence Recovery. A. The fraction
of designable positions in the benchmark complex set where the correct (wild-type) residue identity
was incorporated at least 50% of the time (native sequence recovery) for a range of special_rot
bonus values. Control indicates native sequence recovery when using the unmodified Packer. B.
Box and whisker plots for profile similarities at designable positions in the benchmark set, where
designable positions that achieve a profile similarity of >0.9 regardless of modifications to the
Packer have been removed (plots with all positions are shown in Figure 2.8). C. Scatter plots
showing profile similarity for individual designable positions at various special_rot bonus values
(left: 0; middle: -1.5; right: -4.0) compared to the unmodified Packer. D. Scatter plots showing
shannon entropy for individual designable positions at various special_rot bonus values (left: 0;
middle: -1.5; right: -4.0) compared to the unmodified Packer.
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improvement in profile similarity with the complementary rotamers as compared to the unmodified
Packer (Figure 2.4 panel C, middle). It is important to note that the complementary Rotamer-
Set with a special_rot bonus of -1.5 REU provided an improvement in profile similarity to design
positions without diminishing high-similarity positions in both Packer conditions. On the contrary,
for special_rot bonus values of -4.0 REU and below, profile similarities deteriorate for positions
originally recovered by the unmodified Packer (Figure 2.4 panel C, right).
An additional benefit provided by complementary rotamers becomes evident when considering
sequence entropy at designable positions: inclusion of complementary rotamers with a non-zero
special_rot bonus leads to increased Shannon entropy for designable positions as compared to
the unmodified Packer (Figure 2.4 panel D), while maintaining comparable if not better median
profile similarities up to a value of -4.0 REU for the special_rot bonus (Figure 2.4 panel B). A key
benefit of increased sequence entropy with complementary rotamers is demonstrated by the fre-
quency and variety of polar and charged residues incorporated at several design positions (Figure
2.5). This behavior could lead to improvements over Rosetta’s known propensity to incorporate
small, hydrophobic residues over side chains capable of mediating hydrogen bonds, leading to fre-
quent issues with buried unsatisfied hydrogen bonding donors and acceptors and poor sequence
recovery in polar binding sites.27
2.2.5 Composite Binding Sites and Complementary Rotamers Applied to De Novo
Design of Ligand Binders
Finally, we sought to demonstrate the combined application of the methods outlined in this work
toward improved design of protein-ligand interfaces de novo. We selected 5 ligands from our
match comparison set and selected matches for these ligands for design that passed designability
filters based on ligand burial, composite binding site energy, and potential hydrogen bond satis-
faction with the ligand (Table 2.9). We then designed the binding site environment of the selected
matches using complementary rotamers. While a special_rot bonus of -1.5 was found to provide
the greatest benefit in terms of native sequence recovery and profile similarity in the binding site
recovery benchmark (Figure 2.4 panels A,B), we decided to also attempt complementary rotamers
design with a special_rot bonus of -4.0. to investigate whether increased sequence entropy pro-
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Figure 2.5: Sequence Logos for Recovery of Designable Binding Site Positions. Binding site
recovery is shown for the engineered lipocalin DigA16 in complex with digitoxigenin (PDB ID:
1LNM, Ligand chemical component identifier: DTX). Sequence logos depict positional information
content in bits, where residue identities are colored based on hydrophobicity (hydrophilic, blue;
neutral, green; hydrophobic, black). Designable positions are in Rosetta numbering as in S6 Table.
Design positions in navy blue boxes show improved native sequence recovery with the application
of complementary rotamers. Specifically, positions with polar or charged residues show increased
recovery with increased magnitude in the special_rot bonus. While the native residue identity of
position 91 is not found, an isosteric residue is recovered with the application of complementary
rotamers. Sequence recovery for positions in red boxes is negatively affected with increased
special_rot bonus when compared to the unmodified Packer.
17
Table 2.2: Improved Design Metrics when Using Complementary Rotamers on Composite Binding
Site Matches for 14 De Novo Ligand Binding Site Design Cases. Counts out of 14 cases of design
on composite binding site matches where median metrics across 5000 designs that utilized com-
posite RotamerSets with special_rot bonus values were improved as compared to the unmodified
Packer. Ligand SASA and RosettaHoles are considered improved if the median decreased relative
to the unmodified Packer. Shape complementarity is considered improved if the median increased
relative to the unmodified packer.
special_rot Bonus Ligand SASA RosettaHoles Shape Complementarity
0 6 9 10
-1.5 7 8 11
-3.0 12 9 11
-4.0 12 8 9
vided by a greater magnitude special_rot bonus (Figure 2.4 panel D) would benefit design (and
the benchmark metrics remained comparable to the unmodified Packer up to this bonus). We also
used a special_rot bonus of -3.0 as a midpoint between the aforementioned conditions.
A total of 5000 trajectories were attempted for each design condition and outputs were passed
through commonly applied Rosetta filters to determine the quality of designs. In particular, the
quality of the designs was judged based on shape complementarity of the binding site with the
ligand,31 packing within the binding site based on Rosetta’s Holes32 filter, and ligand solvent ac-
cessible surface area (SASA). These metrics were selected as tightly packed binding sites with
high shape complementarity to the ligand were previously demonstrated to be essential for high
ligand binding affinity and specificity in de novo designed proteins.6
The application of complementary rotamers improved key quality metrics when compared to
design with the unmodified Packer for all special_rot bonus values attempted. Surprisingly, quality
metrics improved even when the special_rot score bonus was set to zero (i.e. complementary
rotamers were included but not favored beyond their Rosetta energies). This behavior is likely due
to the increased degrees of sampling at the χ1 and χ2 torsions for complementary rotamers that
were introduced to the Packer, resulting in finer sampling of rotamer conformations at the protein-
ligand interface. The greatest benefit was imparted with a special_rot bonus of -3.0, where packing
based on the Rosetta Holes score improved in 9/14 of design cases, ligand burial improved in
12/14 of design cases, and shape complementarity with the ligand improved in 11/14 of design
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cases (Table 2.2).
When we focused on design metrics for individual composite binding site matches, we found
that complementary rotamers provided a considerable benefit. For instance, we attempted design
on a composite binding site for (E)-imidacloprid consisting of three leucines matched into the cavity
of the TAP-p15 mRNA nuclear export factor (PDB ID: 1JKG). All metrics were improved compared
to the unmodified packer when complementary rotamers with a special_rot bonus of -1.5 were ap-
plied (Figure 2.6). Importantly, complementary rotamers enriched for designs that possess high
(>0.75) shape complementarity with imidacloprid as well as designs that reduced the amount of
solvent accessible surface area on the ligand. Similarly, application of complementary rotamers
with all special_rot bonus values enriched the number of designs with high shape complementar-
ity and reduced solvent accessible surface area in a composite binding site match for naproxen
(Figure 2.7). Here, a composite binding site composed of tryptophan, tyrosine, and phenylalanine
was matched into the cavity of an NTF2-like protein (PDB ID: 2RCD). Importantly, for both the
imidacloprid and naproxen binding site design cases, application of complementary rotamers did
not merely improve one design metric at the expense of other metrics; complementary rotamers
enriched for designs that were improved in all metrics as compared to designs generated by the
unmodified Packer (Figure 2.6, Figure 2.7). When taken together, these results demonstrate that
applying complementary rotamers to design of composite binding site matches generates designs
for de novo ligand binding sites that exhibit favorable metrics that have been previously shown to
be predictive of design success.
2.3 Discussion
In this work, we demonstrate new methods to improve the design of protein-ligand interfaces
based on interactions observed in the PDB. By decomposing a small molecule into fragments, we
leverage the wealth of structural information in the PDB to assemble pools of protein side chain
interactions with fragments that compose the target ligand. We outline a new method to combine
these discrete protein-fragment contacts into hundreds of thousands of composite binding sites
for target ligands that are incorporated with high precision into scaffold proteins to nucleate a
new binding site. We also outline a new method to bias the incorporation of side chain rotamers
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Figure 2.6: Composite binding sites combined with complementary rotamers improve design qual-
ity metrics for (E)-imidacloprid. A. Spheres indicate the number of complementary rotamers ac-
cepted per position to design the context of an all-leucine composite binding site (purple) for (E)-
imidacloprid (hot pink) placed into the scaffold protein PDBID 1JKG. B. Violin plots depict the dis-
tribution of values obtained for shape complementarity, RosettaHoles, and ligands SASA metrics
after design using complementary rotamers with special_rot bonus values, where Control designs
were generated using the unmodified Packer. Application of complementary rotamers to design
improves key metrics important for de novo design of ligand binding proteins with high specificity
and selectivity. Application of complementary rotamers with the special_rot score bonus (blue) im-
proves design metrics over merely adding complementary rotamers without the special_rot bonus
(green) or the unmodified packer ("Control", red). Shape complementarity increases and Roset-
taHoles and ligand solvent accessible surface area (SASA) decrease. Design metrics improve as
the special_rot bonus is increased from 0.0 to -4.0. C. Histograms on the diagonal show the de-
sign metric distribution for control designs as compared to designs with complementary rotamers
and a special_rot bonus of -4.0 REU. Violin plots show the distributions of each design metrics as
a function of incorporated complementary rotamers. Scatterplots show the correlation between
different design metrics. Designs show simultaneous improvement in shape complementarity and
binding site packing with the application of complementary rotamers.
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Figure 2.7: Composite binding sites combined with complementary rotamers improve design qual-
ity metrics for Naproxen. A. Spheres indicate the number of complementary rotamers accepted
per position to design the context of a composite binding site composed of tryptophan, tyrosine,
and phenylalanine (purple) for naproxen (hot pink) placed in the scaffold protein PDBID 2RCD. B.
Plots and design metrics are as in Figure 2.6. Application of complementary rotamers improve
shape complementarity and ligand SASA with increased special_rot bonus. C. Plots and design
metrics are as in Figure 2.6. Designs show simultaneous improvement in shape complementarity,
ligand SASA, and binding site packing with the application of complementary rotamers.
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that reconstitute known interactions with ligand fragments during design. Finally, we demonstrate
that the combination of these methods improves the quality of designs compared to Rosetta’s
conventional design machinery as determined by commonly used metrics.
The methods outlined in this work serve as a foundation for more complex strategies to design
functional protein-ligand interactions. Protocols such as Rosetta’s FastDesign, which incorporates
a small amount of backbone change into the design process by iterating between fixed-backbone
design and fixed-sequence minimization steps, could include the complementary rotamers de-
scribed here to improve protein-ligand interface design. Other flexible design methods such as
CoupledMoves33 or Backrub Ensembles34 may benefit from the application of complementary
rotamers to further increase design sequence diversity and incorporation of key protein-ligand in-
teractions in a binding site. Similarly, complementary rotamers could be incorporated into other
side chain design approaches.35,36,37
While we were able to demonstrate effective application of protein-fragment interactions to the
design of ligand binding sites, there are several classes of contacts that were not used produc-
tively. For instance, we noticed that 19.3% of fragment interactions in the contact pools generated
for the ligands in this work were found to be mediated by backbone atoms (C, CA, O, N). This pro-
portion agrees with the binding sites in the match comparison benchmark, where 17 of 93 contact
constraints generated for existing complexes (see Methods) were mediated by a backbone atom.
However, our composite binding site method focused on introducing productive side chain interac-
tions with the ligand. In addition, complementary rotamers would not benefit from the addition of
backbone interactions since they may not be introduced once the ligand is placed within a potential
binding site context. It is also well known that water-mediated interactions are frequent in polar
protein-small molecule interfaces38,39 but are not considered here. Updating the method to better
utilize these interactions could improve our ability to design functional protein-ligand interactions
in the future.
Design with complementary rotamers relies on a fixed bonus provided by the special_rot score
term to bias incorporation of observed protein-fragment interactions. While a special_rot bonus
of -1.5 was found to provide the most benefit in native sequence recovery and profile similarity
across all complexes in our benchmark set, the most adequate bonus to maximize these metrics
varied between individual complexes. In addition, we found several design positions in the bind-
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ing site recovery benchmark where the application of complementary rotamers was detrimental to
sequence recovery (see examples in Figure 2.5). More tunable methods of applying bonuses for
each complementary rotamer incorporated during design may provide a more generalizable bene-
fit across varying design contexts. For instance, the design centric guidance terms implemented in
Rosetta could provide a ramping score that provides a significant bonus for the first complemen-
tary rotamer incorporated, then ramp down the bonus for each additional rotamer introduced.40
These metrics could also be implemented to bias incorporation of complementary rotamers that
satisfy certain user-defined constraints such as hydrogen bonding with the ligand.
The methods described in this work provide a new framework for the de novo design of small
molecule binding sites into proteins and directly address key shortcomings in current state-of-the-
art methods for protein-ligand interface design. We drastically expand the possible combinations
of protein-ligand contacts that can be incorporated into scaffold proteins by recombining observed
protein-fragment contacts into composite binding sites, paving the way for the computational de-
sign of new binding sites for targets for which no co-complex structure exists in the PDB. To
complement shortcomings in Rosetta’s energy function with regards to ligands, we also apply
contact pools to bias the design of protein-ligand interfaces toward contacts that are frequently ob-
served to mediate interactions with defined ligand substructures in the PDB. When combined with
Rosetta’s success in de novo protein designed protein structures, we provide a foundation for the
complete de novo design of functional ligand-binding proteins. For instance, where most existing
methods attempt to build a binding site into an existing scaffold, just as we have demonstrated
with three-residue composite binding sites and RosettaMatch, composite binding sites of arbitrary
size can instead serve as a scaffold to build functionalized de novo proteins from the inside-out.
We envision that composite binding sites and complementary rotamers will pioneer the design of
proteins tailor built for specific functions and will augment our ability to design sensors and in-
ducible transcription factors that require complex understanding of how protein-ligand interactions
mediate chemistry and allostery.
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2.4 Methods
2.4.1 Code Availability
The collection, processing, and application of contact pools derived from observed protein-ligand
fragment interactions in the PDB is implemented as a Python3 package called BindingSites-
FromFragments (BSFF). BSFF builds upon the Rosetta Molecular Modeling Suite,5 PyRosetta
(PyRosetta4.conda.linux.CentOS.python37.Release r240 2019.50+release.91b7a94),41 ProDY,42
and RDKit.26 Each step of the protocol is accessible through a command-line interface with min-
imal intervention by the user after generating the initial inputs. BSFF creates and automatically
populates a directory tree named with a three-letter code (typically the ligand’s three character
PDB identifier, referred to here as [/TGT]) in a user-defined location. All scripts and commands
are included as part of the BSFF Repository (https://github.com/jaaamessszzz/ BindingSitesFrom-
Fragments). Additional scripts for generating figures and submitting jobs are also available (https://
github.com/jaaamessszzz/BindingSitesFromFragments-Utilities).
2.4.2 Prepare Input Files
BSFF requires a Sybyl MOL2 representation of the target ligand as an initial input. For lig-
ands with rotatable bonds, we used OpenEye Omega (version 2.5.1.4)25 with default settings
to generate a conformer library. A custom script (molfile_split_into_singles.py) uses Rosetta’s
molfile_to_params.py to generate a Rosetta params file for each ligand conformer. PDB repre-
sentations of each conformer are also generated by molfile_split_into_singles.py so that unique
atom names are consistent across all ligand conformers. These files are written to [/TGT/Input-
s/Rosetta_Inputs].
2.4.3 Define Fragments
Avogadro43 is used to generate user-defined fragments (a subset of atoms from the target lig-
and) derived from a single PDB representation produced in the previous step. This step relies
on the user’s chemical intuition to define fragments that represent local chemical substructures
of the target ligand, which will be used to search the PDB to collect protein contacts with each
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defined fragment. Each ligand fragment is saved as a PDB file and must conserve the unique
atom names found in the full PDB representation of the target ligand. Typically, 5-10 fragments
consisting of 3-10 atoms each are generated for a target ligand. The PDB representations of each
fragment should be saved as Fragment_X.pdb to [/TGT/Inputs/Fragment_Inputs], where each frag-
ment should be enumerated (replacing X in Fragment_X.pdb with fragment index).
2.4.4 Search for Protein-Fragment Interactions
PubChem substructure search44 is used to identify small molecules that possess user-defined
fragments as substructures. For each fragment, the PDB representation generated in the previ-
ous step is imported into the PubChem Sketcher Tool and converted into a SMILES string. Atom
query attributes are defined to restrict search results to small molecules that possess user-defined
fragments as substructures with the same connectivity and local chemical environment (e.g. bond
order, aromaticity) as the target molecule. Explicit hydrogens are not removed before search-
ing. A molecular weight cutoff of 800Da is applied to the search results. The top 1,000,000
search results are downloaded as a CSV file (cid, inchikey) and saved as Fragment_X.csv to
[/TGT/Inputs/Fragment_Inputs], where the CSV name should correspond to the input fragment
PDB. Complete SMILES search queries for each fragment are to be enumerated and saved in
Fragment_Inputs.csv found in [/TGT/Inputs/Fragment_Inputs].
For each fragment, an intersection of PubChem search results with a complete list of ligands
represented in the PDB from LigandExpo45 yields all fragment-containing small molecules that
may be found in complex with a protein in the PDB. For each fragment-containing molecule, the
PDB REST API returns all structures with a 90% sequence identity cutoff where the small molecule
is in complex with a protein (all complexes containing DNA/RNA are excluded). Ligands and
protein-ligand complexes for each fragment are stored under [/TGT/PDB_search_results.json].
Alternatively, the Chemical Component Search function available through the PDB can be used
to populate [/TGT/PDB_search_results.json]. Using this function may find compounds that are
missed by PubChem, but at the expense of significant limitations in the ability to define fragment
chemical environments in the search query.
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2.4.5 Align
All protein-ligand complexes found in the previous step are processed to consolidate protein con-
tacts in reference to each user-defined fragment. For each fragment-containing compound in a
protein-ligand complex, the structure is checked to verify that 1) the ligand does not possess multi-
ple occupancies and 2) all ligand atoms are resolved. If the structure passes these quality checks,
the fragment substructure in the ligand is identified using SMILES representations and the Maxi-
mum Common Substructure search as implemented by RDKit. For each substructure contained
within a ligand, all protein atoms within 12Å of the fragment substructure (including the fragment)
are extracted and transformed such that the identified substructure is superimposed onto the user-
generated PDB representation of the fragment. This process produces an aligned ensemble of all
protein contacts with the defined fragment in the PDB that pass all quality filters.
2.4.6 Cluster
Agglomerative hierarchical clustering is performed for each fragment’s ensemble of protein inter-
actions to identify highly represented protein-fragment contacts. A feature vector is generated for
residue in the ensemble consisting of: spatial position relative to the fragment, contact distance, in-
teraction chemistry, and residue identity (Table 2.6). A filtering step removes hydrophobic residues
(ACFGILMPVW) >4Å from any fragment atom or polar residues (DEHKNQRSTY) >3.5Å from any
fragment atom. Residues are first clustered by protein-fragment interaction chemistry (Hamming
distance, cutoff=2, linkage=complete) followed by spatial distribution about the fragment (Cosine
distance, cutoff= 1−cos(20∗pi/180), linkage=average) to generate clusters of residues that mediate
similar interaction types with specific parts of the target fragment.
2.4.7 Fragment Contact Analysis
Bootstrapping was applied to approximate the proportion of protein-fragment contact clusters (i.e.
contact modes) that would be recovered given an observed fraction of the PDB. For a given frag-
ment and sample size (ranging from 0% to 100% of the PDB at 5% intervals), 1000 samples were
drawn from the PDB and the number of recovered clusters were recorded. Clusters were consid-
ered recovered if at least one contact in the cluster was sourced from a PDB in the sample. The
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average fraction and standard deviation of clusters recovered were reported for each fragment
and sample size and are shown in Figure 2.2.
2.4.8 Contact Pool Assembly
All clustered protein-fragment contacts are positioned relative to their source fragments in the
target ligand to produce an ensemble of aligned protein contacts with the full target ligand. For lig-
and conformers, sidechains are transformed using three atoms each on the ligand and sidechain
to maintain the contact geometry observed in the PDB. Additional filters are applied to remove
redundant contacts and remove contacts from structures with missing (zero occupancy) protein
atoms or alternative protein conformations (residues with ALTLOC records). Contacts are consid-
ered redundant if a sidechain has already been accepted with equivalent sidechain contact atoms,
equivalent ligand contact atom, sidechain contact atoms RMSD ≤0.5Å, and Cα atom distance
≤1.5Å. Contact pools are limited to the best 5000 contacts as determined by Rosetta energy. Fur-
thermore, the addition of hydrogen bond donors/acceptors (as determined by a negative hbond_sc
score for the contact) to the contact pool are prioritized (up to 500 residues per donor/acceptor
atom on the ligand) and remaining contacts are equally distributed about the ligand based on the
ligand atom mediating contact with each residue. Alanine, glycine, proline, and cysteine residues
were not added to contact pools in this work.
2.4.9 Assembly of Composite Binding Sites
For each target ligand conformer, a Markov Chain Monte Carlo protocol was applied to assemble
discrete sidechains in the contact ensemble into composite binding sites. A composite binding site
is initialized with three random sidechains from the contact ensemble and select two-body score
terms in the Rosetta full-atom energy function (fa_rep, fa_atr, fa_elec, hbond_sc, fa_sol) are used
to evaluate the overall energy of the binding site. During each move, a sidechain in the current
binding site is replaced with a random sidechain from the contact ensemble. The new binding site
is scored and the move is kept based on the Metropolis criterion, where the objective is to minimize
the energy of the composite binding site. The temperature is ramped down geometrically across
seven steps. Up to ten trajectories are performed for each contact ensemble and the lowest energy
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100,000 solutions discovered per trajectory are recorded.
Selection of Binding Site Definitions for Existing Complexes. Binding site definitions were gen-
erated for existing protein-ligand complexes in the Match comparison benchmark. These con-
straints consist of the three lowest-energy contacts in the binding site for the given complex in
terms of the two-body Rosetta energies used to assemble contact pools (fa_rep, fa_atr, fa_elec,
hbond_sc, fa_sol) and the hbond_bb_sc term to account for binding site backbone contacts with
the ligand. Existing protein-ligand complexes were relaxed with the Rosetta FastRelax protocol
with the full REF2015 energy function and starting coordinate constraints (FastRelax command
line option -relax:constrain_relax_to_start_coords) before determining constraint contacts.
2.4.10 Match Binding Sites into Scaffolds
RosettaMatch14 is used to find binding site solutions that may be accommodated by existing back-
bone geometries in a protein scaffold set. A monomeric scaffold set was previously assembled.6
RosettaMatch constraint files are automatically generated for the best 5,000 binding site solutions
across all ligand conformers in terms of objective value (Rosetta energy). Constraint files are gen-
erated for the RosettaMatch algorithm using a custom script that calculates six degrees of freedom
(1 distance, 2 angles, 3 torsions) for three ligand atoms and three side chain atoms that mediate
the ligand-protein side chain interaction. Each angle and torsion degree of freedom is sampled at
±5◦ in addition to the ideal value, while the distance is fixed at the ideal value. Additional flags
for the RosettaMatch application are as follows: -ex1 -ex2 -extrachi_cutoff 0 -bump_tolerance
0.5 -euclid_bin_size 1 -euler_bin_size 10 -match:consolidate_matches -match_grouper SameRo-
tamerComboGrouper -output_matches_per_group 1.
Successful matches must pass additional filters where 1) the binding site energy as calculated
in the context of the scaffold <0, 2) max fa_rep for any motif residue <25 Rosetta energy units
(REU), and 3) max fa_sol for any motif residue <5 REU. A custom "hydrogen bond satisfaction"
filter is also applied to ensure that positions exist in the match scaffold where a sidechain can be
built to satisfy all potential hydrogen bond donor/acceptor atoms on the ligand. This filter generates
rotamers (-ex1 -ex2 -extrachi_cutoff 0) for all positions within 10Å of the ligand. The filter reports
which hydrogen bond donor/acceptor atoms on the ligand that are satisfied for all contacts found
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where hbond_sc < 0, fa_rep < 10, and the sum of two-body terms used to solve for composite
binding sites < 10.
2.4.11 Selection of Binding Site Recovery Benchmark Set
Protein-ligand complexes for the binding site recovery benchmark were identified using the Bind-
ingMOAD30 with the following search criteria: binding class, ligand mass of 200 - 800 Da, <1µM
dissociation constant (KD), and crystal structure of <2.5Å resolution. In addition to these criteria,
complexes were further curated for binding sites composed of mainly side chain interactions, lig-
ands with less than six rotatable bonds, and few waters and no metal coordination in the binding
site. A set of 22 protein-ligand complexes was identified for the benchmark (Table 2.5). PDB ID
6M9B was used in place of BindingMOAD annotated streptavidin-biotin complexes.
2.4.12 Generation of Complementary Rotamers
Complementary rotamers are generated per-position in a protein-ligand interface to augment the
set of rotamers Rosetta’s Packer will use to design the binding site. Complementary rotamers are
created in two steps. First, a new contact pool is assembled for the ligand placed into the scaffold
in the protein-ligand complex. In addition to the aforementioned criteria for contact pool assembly,
inverse rotamers14 are generated for potential contacts in the context of the ligand binding site and
are only added to the new contact pool if an inverse rotamer’s mainchain (C, CA, N) RMSD to any
position in the protein backbone is 2Å or less. This process yields a contact pool for interactions
that may potentially be recapitulated within the context of the protein-ligand interface. Second,
rotamers are generated for designable positions in the protein-ligand interface with extra χ-angle
sampling at two half-step standard deviations for χ1 and χ2 (-packing:ex1:level 4 -packing:ex2:level
4) and one standard deviation for χ3 and χ4 (-packing:ex3:level 1 -packing:ex4:level 1). Rotamers
that recapitulate contact geometries observed in the target ligand contact pool with RMSD ≤
1.5Å are added to Rosetta’s Packer RotamerSets. By default, up to 50 rotamers are added per
residue identity to a position’s RotamerSet, where each rotamer is flagged with the SPECIAL_ROT
VariantType. If more than 50 rotamers are found to recapitulate contact pool interactions for a
given position and residue identity, only the best rotamers by Rosetta energy are added to the
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RotamerSet.
2.4.13 Design with Complementary Rotamers
Protein-ligand complexes (e.g. matches, or existing complexes from the PDB) are passed to con-
ventional Rosetta design methods to redesign the binding site environment with the aid of com-
plementary rotamers. The binding site environment is designed using fixed backbone packing as
implemented in Rosetta15 where the Packer RotamerSets are augmented with complementary ro-
tamers flagged with the SPECIAL_ROT VariantType. All protein positions within 10Å of the ligand
with Cα-Cβ vectors pointing toward the ligand (i.e. dot product of Cα-Cβ vector and Cα-centroid
vectors > 0) are set to designable (i.e., allowed to change residue identity). In addition, these po-
sitions are passed to the ClashBasedShellSelector to identify a first shell of residues that are also
set to designable. All designable positions are again passed to the ClashBasedShellSelector to
identify a second shell of residues that are set to repackable (i.e., allowed to change conformation
while keeping the residue identity the same). All other positions in the protein are fixed during
design. All cysteines, glycines, and prolines in the protein are fixed. The following flags were
used for design: -ex1 -ex2 -extrachi_cutoff 0 -use_input_sc -run:preserve_header -extra_res_fa
params_path -total_threads 1, where params_path is the path to the params file for the ligand in
the complex. Up to 10,000 independent design simulations are performed for each match with
the special_rot score term added to the default REF2015 energy function to bias incorporation of
complementary rotamers during design. For de novo binder design, matched binding site residues
are set to repack only and constraints as defined during matching are applied using the AddOr-
RemoveMatchCsts mover to maintain contact geometries with the ligand during design. Rosetta
filters were used to compute shape complementarity,31 RosettaHoles score,32 and ligand solvent
accessible surface area metrics. The Binding Strain, Residue Interaction Energy, PackStat, and
BuriedUnsatHbonds filters were also computed, but were less informative (S1 Appendix). An ad-
ditional entry for chlorine (radius of 1.75Å) was added to the shape complementarity atom radius
database file [database/scoring/score_functions/sc/sc_radii.lib] for ligands that contain chlorine
atoms.
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2.4.14 Profile Similarity and Sequence Recovery
For the binding site recovery benchmark, profile similarity was calculated at each design position
as previously described,33 where profile similarity is defined as 1 - Jensen-Shannon Divergence.46
Jensen-Shannon Divergence was calculated per position for design sequences against the native
complex sequence taken from the PDB. For sequence recovery, design positions were considered
recovered if >50% of design sequences incorporated the residue identity observed in the native
complex.
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2.6 Supplemental
2.6.1 Tables
Table 2.3: Statistics for Fragments Used to Investigate Contact Diversity. Kekule structures and
corresponding SMILES strings are provided for all fragments used to investigate the availability
of protein-fragment contact information in the PDB. The total number of unique residue-fragment
contacts and the number of unique clusters (i.e. contact modes) represented by these residue-
fragment contacts are reported.
Fragment SMILES Total Residues Total Clusters
Fraction PDB Sampled for
>80% Contact Recovery
[N;v3,v4]=C([N;v3]([H])[H])[N;v3]([H])[H] 3699 467 0.45
CC(=O)N([H])[H] 19077 932 0.35
CC(=O)O[H] 64489 1699 0.20
C1=C([N](C(=N1)[H])[H])[H] 3722 592 0.40
C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H] 6432 492 0.40
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2.3 Continued
Fragment SMILES Total Residues Total Clusters
Fraction PDB Sampled for
>80% Contact Recovery
C([H])([H])C([N+]([H])([H])[H])([H])[H] 2814 442 0.50
C1=C(C(=C(C(=C1[H])[H])[H])[H])[H] 10063 746 0.35
C1=C([N]([H])C2=C([H])C(=C(C(=C12)[H])[H])[H])[H] 2089 314 0.55
N1=C(C(=C(C(=C1[H])C(=O)N([H])[H])[H])[H])[H] 3414 319 0.45
N2=C1C(=C(N([H])[H])N=C([N]1)[H])N=C2[H] 68520 1046 0.25
N1C=CC(=NC1=O)N([H])[H] 2123 282 0.50
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2.3 Continued
Fragment SMILES Total Residues Total Clusters
Fraction PDB Sampled for
>80% Contact Recovery
N1C(=O)N(C(=O)C(=C1[H])C([H])([H])[H])[H] 2116 228 0.50
[N]1C(=NC2=C1N=C(N(C2=O)[H])N([H])[H])[H] 12387 580 0.40
N1C(N(C(C(=C1[H])[H])=O)[H])=O 6040 440 0.45
[C]1([C@H](O[H])[C@@H]([C@H](O1)C(O)
([H])[H])O[H])([H])[H]
11621 754 0.35
C1=NC=CS1 1573 215 0.55
C1SCC2NC(=O)NC12 1051 34 0.20
40
2.3 Continued
Fragment SMILES Total Residues Total Clusters
Fraction PDB Sampled for
>80% Contact Recovery
C1(C(CC(=C2C(C([C@@H]3[C@@H]([C@@]12C
([H])([H])[H])C(C([C@]4([C@H]3C(C(C4[H])([H])[H])
([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])
[H])[H])([H])[H])([H])[H]
511 102 0.55
N3=C2C(=NC1=C(C=C(C(=C1)C)C)N2)C(NC3=O)=O 21494 685 0.30
[C]1=CC(=[C][C]=[C]1)C(=O)N([H])[H] 284 84 0.65
C1=CC=C(C=C1)O[H] 12964 896 0.35
N1=N[N]C=N1 166 52 0.65
O=[P](O)(O[H])O 78948 1371 0.15
41
2.3 Continued
Fragment SMILES Total Residues Total Clusters
Fraction PDB Sampled for
>80% Contact Recovery
[S](=O)(=O)(N)C 1631 252 0.45
C1=C2C(=CC=C1)C=NC=C2 533 126 0.60
C1=CC(=CC=C1)[Cl] 7592 599 0.40
C1=CN=CC=C1 17058 755 0.35
[C]1[C][C][N][C][C]1 18883 811 0.35
C1=CN=CN=C1 52449 995 0.25
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2.3 Continued
Fragment SMILES Total Residues Total Clusters
Fraction PDB Sampled for
>80% Contact Recovery
N1[C][C]N[C][C]1 3799 551 0.45
FC1=CC=CC=C1 4243 523 0.45
O=C1NC(=O)CC[C]1 170 26 0.65
C1(C=CC(N1)=O)=O 485 82 0.60
C1=CCOC1=O 357 96 0.65
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Table 2.4: Application Ligands. Full name and chemical component identifier for ligands used for
the Match comparison benchmark and forward design with matched composited binding sites. All
existing PDBs where a protein creates a contact interface with the ligand are provided.
Ligand Chemical Component
Identifier
Complex PDB(s)
(5Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-
2,3-dimethyl-3,5-dihydro-4H-imidazol-4-one
38E 6CZH, 6CZI
8,9-DIHYDRO-9-HYDROXY-AFLATOXIN B1 AFN None.
ATRAZINE ATZ 5PRC
DIGOXIGENIN DOG 1LKE, 3RA7, 4J8T, 5BVB
IBUPROFEN IBP 6U4X, 5JQB, 4RS0, 4PH9, 4JTR, 3P6H,
3IB2, 2WD9, 2PWS, 2BXG, 1EQG
(E)-imidacloprid IM4 3WTH, 3C79
LUMIFLAVIN LFN 6ASL, 2CCC
Naproxen NPS 4ZBR, 4OR0, 4PO0, 4JQ1, 4FJP, 3R58,
3NT1, 2VDB
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Table 2.5: BindingMOAD Complexes used for Binding Site Sequence Recovery. PDB ID, PDB
description, ligand chemical component identifier, and full ligand name for BindingMOAD protein-
ligand complexes applied in the binding site recovery benchmark.
PDB PDB Description Ligand Ligand Name
6M9B Wild-type streptavidin in complex with biotin solved by native SAD with data
collected at 6 keV
BTN Biotin
5T52 LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH GALNAC NGA N-ACETYL-D-GALACTOSAMINE
1LNM ANTICALIN DIGA16 IN COMPLEX WITH DIGITOXIGENIN DTX DIGITOXIGENIN
5HZ6 FABP4 in complex with 6-Chloro-2-isopropyl-4-(3-isopropyl-phenyl)-
quinoline-3-carboxylic acid
65Y 6-Chloro-2-isopropyl-4-(3-isopropyl-phenyl)-quinoline-3-carboxylic
acid
5HZ8 FABP4_3 in complex with 6,8-Dichloro-4-phenyl-2-piperidin-1-yl-quinoline-
3-carboxylic acid
65Z 6,8-dichloro-4-phenyl-2-(piperidin-1-yl)quinoline-3-carboxylic acid
1LKE ENGINEERED LIPOCALIN DIGA16 IN COMPLEX WITH DIGOXIGENIN DOG DIGOXIGENIN
1N0S ENGINEERED LIPOCALIN FLUA IN COMPLEX WITH FLUORESCEIN FLU 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID
3OKI Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-
1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide
OKI (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-
dicyclohexylethanamide
5EDB human fatty acid binding protein 4 in complex with 6-Chloro-2-methyl-4-
phenyl-quinoline-3-carboxylic acid at 1.18A
5M8 6-chloranyl-2-methyl-4-phenyl-quinoline-3-carboxylic acid
5URA Enantiomer-Specific Binding of the Potent Antinociceptive Agent SBFI-26 to
Anandamide transporters FABP7
8KS (1S,2S,3S,4S)-3-[(naphthalen-1-yl)oxy]carbonyl-2,4-
diphenylcyclobutane-1-carboxylic acid
1SRI STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS
FOR STREPTAVIDIN
DMB 2-((3’,5’-DIMETHYL-4’-HYDROXYPHENYL)AZO)BENZOIC ACID
1TOU Crystal structure of human adipocyte fatty acid binding protein in complex
with a non-covalent ligand
B1V 2-[(2-OXO-2-PIPERIDIN-1-YLETHYL)SULFANYL]-6-
(TRIFLUOROMETHYL)PYRIMIDIN-4-OL
2IZL STREPTAVIDIN-2-IMINOBIOTIN PH 7.3 I222 COMPLEX IMI 2-IMINOBIOTIN
4AFH Capitella teleta AChBP in complex with lobeline L0B Alpha-Lobeline
4QAC X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN
(ACHBP) IN COMPLEX WITH 4-(4-methylpiperidin-1-yl)-6-(4-
(trifluoromethyl)phenyl)pyrimidin-2-amine
KK3 4-(4-methylpiperidin-1-yl)-6-[4-(trifluoromethyl)phenyl]pyrimidin-2-
amine
2QRY Periplasmic thiamin binding protein TPS THIAMIN PHOSPHATE
4AFG Capitella teleta AChBP in complex with varenicline QMR VARENICLINE
4B5D Capitella teleta AChBP in complex with psychonicline (3-((2(S)-
Azetidinyl)methoxy)-5-((1S,2R)-2-(2-hydroxyethyl)cyclopropyl)pyridine)
SW4 2-[(1R,2S)-2-[5-[[(2S)-azetidin-2-yl]methoxy]pyridin-3-
yl]cyclopropyl]ethanol
5J5G X-Ray Crystal Structure of Acetylcholine Binding Protein (AChBP) in Com-
plex with 6-(4-methoxyphenyl)-N4,N4-bis[(pyridin-2-yl)methyl]pyrimidine-
2,4-diamine
6GF 6-(4-methoxyphenyl)-N 4 ,N 4 -bis[(pyridin-2-yl)methyl]pyrimidine-
2,4-diamine
3CZ1 Dimeric crystal structure of a pheromone binding protein from Apis mellifera
in complex with the n-butyl benzene sulfonamide at pH 7.0
NBB N-BUTYL-BENZENESULFONAMIDE
2XN3 Crystal structure of thyroxine-binding globulin complexed with mefenamic
acid
ID8 2-[(2,3-DIMETHYLPHENYL)AMINO]BENZOIC ACID
5J5I X-Ray Crystal Structure of Acetylcholine Binding Protein (AChBP) in Com-
plex with 4-(2-amino-6-bis[(pyridin-2-yl)methyl]aminopyrimidin-4-yl)phenol
6GM 4-(2-amino-6-bis[(pyridin-2-yl)methyl]aminopyrimidin-4-yl)phenol
45
Table 2.6: Feature Vector Components. Descriptions of individual feature vector components used
to cluster residue-fragment interactions into unique contact modes using hierarchical agglomera-
tive clustering.
Value Description
Angstroms X component, vector from fragment centroid to closest residue atom
Angstroms Y component, vector from fragment centroid to closest residue atom
Angstroms Z component, vector from fragment centroid to closest residue atom
0 | 1 Sidechain contact (1) OR backbone contact (0)
0 | 1 Ligand Polar Contact (1) OR Ligand Non-polar Contact (0)
0 | 1 Side chain possesses (1) or does not possess (0) hydrogen bond donor/acceptor (DEHKNQRSTY)
0 | 1 Hydrophobic, aliphatic (AILV) contact (1) or not (0)
0 | 1 Hydrophobic, aromatic (FWY) contact (1) or not (0)
0 | 1 Polar (NCQMST) contact (1) or not (0)
0 | 1 Charged, Acidic (DE) contact (1) or not (0)
0 | 1 Charged, Basic (HKR) contact (1) or not (0)
0 | 1 Glycine contact (1) or not (0)
0 | 1 Proline contact (1) or not (0)
0 | 1 Backbone carbonyl contact (1) or not (0)
0 | 1 Backbone amino contact (1) or not (0)
0 | 1 Backbone C/CA contact (1) or not (0)
Table 2.7: Counts for Improved Metrics Across All Attempted Designs. Counts out of 14 com-
posite binding site matches where median metrics across 5000 designs that utilized composite
RotamerSets with special_rot bonuses were improved or impared as compared to designs gen-
erated with unmodified Packer. Ligand SASA, binding strain (bindingstrain), PackStat, residue
interaction energy (residueie), and shape complementarity are considered improved/impaired if
the median increased/decreased 10% relative to the unmodified Packer. RosettaHoles is consid-
ered improved/impared if the median increased/decreased by 0.25 units relative to the unmodified
packer. Number of hydrogen bonds made with the ligand (hbonds) and heavy buried unsatisfied
hydrogen bond donor/acceptor count (heavyburiedunsats) is considered improved/impaired if the
median count is more/less than the median count for the unmodified Packer.
special_rot bonus bindingstrain hbonds heavyburiedunsats holes packstat residueie ligand_sasa shapecomplementarity
0 7 1 2 9 11 8 6 10
-1.5 6 1 1 8 7 7 7 11
-3.0 2 3 0 9 8 8 12 11
-4.0 2 3 2 8 8 5 12 9
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Table 2.8: Binding Site Benchmark Design Details. Statistics for complementary rotamers gener-
ated and applied to the binding site recovery benchmark. Rosetta numbering and the correspond-
ing PDB numbering for scaffold PDBs are provided. Here we report the number of designable
positions as well as the number of complementary rotamers generated, accepted (i.e. passed
Rosetta energy and RMSD filters, see Methods), and applied to design for each benchmark bind-
ing site. Only the best 50 rotamers per residue type per position were applied top design.
Benchmark
Complex
Designable Positions
(Rosetta numbering)
Designable Positions
(PDB numbering)
Total rotamers,
accepted
Total rotamers,
applied
Total rotamers,
generated
Designable positions,
count
5edb-
clean
13, 16, 19, 20, 22, 23, 24,
26, 28, 30, 33, 36, 39, 56,
58, 60, 61, 63, 77, 78, 79,
80, 107, 127, 129, 131
11A ,14A ,17A ,20A ,21A
,24A ,26A ,34A ,37A ,41A
,43A ,52A ,54A ,56A ,58A
,59A ,61A ,75A ,76A ,77A
,105A ,116A ,125A ,127A
,129A
7972 1544 123299 26
5HZ6-
clean
10, 13, 16, 19, 20, 23, 25,
29, 30, 32, 33, 36, 40, 41,
51, 53, 54, 55, 57, 58, 59,
60, 74, 75, 76, 77, 124,
126, 128
11A ,14A ,17A ,20A ,21A
,26A ,30A ,31A ,33A ,34A
,37A ,41A ,43A ,52A ,54A
,55A ,56A ,58A ,59A ,60A
,61A ,75A ,76A ,77A ,114A
,116A ,125A ,127A ,129A
9768 2024 166273 29
5HZ8-
clean
14, 17, 20, 23, 24, 29, 34,
37, 40, 44, 57, 59, 61, 62,
64, 78, 79, 80, 81, 108, 110
,119, 121, 130, 132
11A ,14A ,17A ,20A ,21A
,26A ,31A ,34A ,37A ,38A
,41A ,54A ,56A ,58A ,59A
,61A ,75A ,76A ,77A ,105A
,107A ,114A ,116A ,118A
,127A ,129A
10876 1901 110344 25
5J5G-
clean
151, 152, 193, 200, 253,
274, 276, 277, 278, 279,
296, 324, 325, 332, 333,
334, 335, 385
143A ,144A ,146A ,148A
,185A ,190A ,192A ,32B
,34B ,36B ,53B ,55B ,56B
,57B ,58B ,73B ,81B ,101B
,103B ,104B ,106B ,111B
,112B ,113B ,114B ,164B
3798 471 47205 18
5J5I-clean 42, 61, 63, 65, 66, 111,
112, 119, 120, 121, 122,
172, 364, 365, 367, 404,
405, 406, 411, 413
-6A ,32A ,34A ,36A ,53A
,55A ,57A ,58A ,73A ,78A
,81A ,99A ,101A ,103A
,104A ,106A ,111A ,112A
,113A ,114A ,164A ,143E
,144E ,146E ,183E ,184E
,185E ,190E ,192E
2720 604 62164 20
5ura-clean 13, 16, 19, 20, 22, 23, 24,
28, 32, 33, 35, 37, 38, 39,
56, 58, 60, 61, 63, 77, 78,
79, 80, 118, 120, 129, 131
11A ,14A ,17A ,20A ,21A
,26A ,33A ,35A ,37A ,41A
,54A ,56A ,58A ,59A ,61A
,75A ,76A ,77A ,105A
,116A ,118A ,127A ,129A
6594 1636 130454 27
1TOU-
clean
10, 13, 16, 29, 33, 36, 37,
39, 52, 53, 54, 55, 57, 58,
59, 60, 61, 74, 75, 76, 77,
93, 104, 115, 126
9A ,10A ,13A ,16A ,19A
,20A ,25A ,32A ,33A ,36A
,37A ,39A ,40A ,41A ,42A
,51A ,53A ,54A ,55A ,57A
,58A ,59A ,60A ,74A ,75A
,76A ,113A ,115A ,124A
,126A ,128A
413 177 51463 25
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2.8 Continued
Benchmark
Complex
Designable Positions
(Rosetta numbering)
Designable Positions
(PDB numbering)
Total rotamers,
accepted
Total rotamers,
applied
Total rotamers,
generated
Designable positions,
count
6m9b-
clean
9, 10, 11, 13, 15, 29, 30,
31, 32, 33, 35, 36, 40, 63,
65, 72, 74, 75, 76, 92, 94,
96, 110, 114, 116, 222,
224, 225
15A ,16A ,17A ,19A ,21A
,35A ,36A ,37A ,38A ,39A
,41A ,42A ,45A ,46A ,48A
,67A ,69A ,71A ,73A ,78A
,80A ,82A ,100A ,102A
,116A ,120A ,122A ,110D
,112D ,113D
12346 2964 148958 28
1sri-clean 11, 12, 13, 15, 17, 31, 33,
34, 35, 37, 38, 42, 62, 64,
71, 73, 74, 75, 77, 91, 93,
95, 109, 113, 115
23A ,24A ,25A ,27A ,29A
,43A ,45A ,46A ,47A ,49A
,50A ,54A ,56A ,75A ,77A
,79A ,86A ,88A ,89A ,90A
,92A ,106A ,108A ,110A
,124A ,128A ,130A ,118B
,120B ,121B
6827 2017 124187 25
1lke-clean 24, 27, 30, 31, 34, 35, 41,
43, 52, 54, 65, 82, 84, 89,
91, 95, 110, 116, 118, 120,
122
28A ,31A ,35A ,38A ,39A
,45A ,47A ,56A ,58A ,69A
,84A ,86A ,88A ,93A ,95A
,99A ,114A ,127A ,129A
,131A
15647 3260 135535 21
1lnm-
clean
24, 27, 30, 31, 34, 35,
41, 43, 52, 54, 65, 80,
81, 82, 83, 84, 86, 91, 92,
95,110,119,121,123
28A ,31A ,35A ,38A ,39A
,45A ,47A ,56A ,58A ,60A
,69A ,73A ,84A ,86A ,88A
,90A ,93A ,95A ,99A ,114A
,127A ,129A ,131A
9306 2132 142313 24
1n0s-
clean
28, 31, 45, 56, 58, 60, 69,
73, 84, 86, 88, 95, 97, 99,
100, 113, 114, 126, 127,
129, 131, 292
11A ,19A ,28A ,31A ,45A
,47A ,56A ,58A ,60A ,69A
,73A ,84A ,86A ,88A ,90A
,95A ,97A ,99A ,100A
,102A ,111A ,113A ,114A
,127A ,128A ,129A ,131A
,154A
11272 2171 126015 22
2XN3-
clean
2, 5, 9, 218, 220, 222, 228,
230, 248, 251, 252, 254,
255, 256, 258
20A ,23A ,24A ,27A ,225A
,227A ,229A ,236A ,238A
,240A ,246A ,248A ,250A
,266A ,268A ,269A ,270A
,272A ,273A ,276A
1145 358 105834 15
2IZL-clean 11, 12, 13, 15, 31, 32,
33, 34, 35, 37, 38, 42,
65, 67, 74, 76, 78, 80, 96,
98,112,116,2 30, 231
23B ,24B ,25B ,27B ,29B
,43B ,45B ,46B ,47B ,49B
,50B ,54B ,56B ,75B ,77B
,79B ,86B ,88B ,90B ,92B
,106B ,108B ,110B ,124B
,128B ,130B ,118D ,120D
,121D ,124D
7597 1843 97588 24
4QAC-
clean
95, 97, 150, 151, 152, 153,
154, 187, 189, 196, 198,
247, 264, 310, 325, 327
19A ,85A ,87A ,89A ,139A
,142A ,143A ,144A ,145A
,146A ,183A ,185A ,190A
,192A ,194A ,36B ,53B
,55B ,73B ,99B ,102B
,104B ,106B ,112B ,114B
,116B ,164B
4164 911 59939 16
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2.8 Continued
Benchmark
Complex
Designable Positions
(Rosetta numbering)
Designable Positions
(PDB numbering)
Total rotamers,
accepted
Total rotamers,
applied
Total rotamers,
generated
Designable positions,
count
4AFH-
clean
98, 100, 102, 152, 153,
154, 155, 156, 192, 194,
201, 277, 325, 328, 341,
388
25A ,98A ,100A ,102A
,108A ,152A ,153A ,154A
,155A ,156A ,192A ,194A
,201A ,43B ,64B ,66B ,88B
,112B ,115B ,128B ,175B
3767 1227 92145 16
3CZ1-
clean
32, 33, 37, 43, 46, 47, 48,
50, 51, 54, 56, 57, 99, 100,
102, 103, 106, 107, 114,
115, 116, 117, 122, 125
13A ,17A ,34A ,35A ,39A
,48A ,49A ,50A ,52A ,53A
,58A ,59A ,70A ,73A ,74A
,92A ,101A ,102A ,104A
,105A ,108A ,109A ,115A
,116A ,117A ,118A ,119A
,9B ,12B ,16B
2949 1257 111069 24
5t52-clean 43, 77, 78, 93, 94, 97, 98,
106, 122, 124, 125, 126,
127, 129
42A ,43A ,77A ,78A ,93A
,94A ,97A ,98A ,102A
,122A ,124A ,125A ,126A
,127A ,209A ,210A ,212A
,213A
5968 1013 63733 14
3oki-clean 21, 22, 27, 28, 31, 35, 36,
41, 44, 45, 48, 49, 52, 86,
87, 89, 90, 91, 92, 93, 94,
106, 109, 110, 113, 115,
120, 123, 126, 127, 201,
208, 212
264A ,267A ,268A ,273A
,274A ,277A ,281A ,287A
,290A ,291A ,293A ,294A
,295A ,298A ,299A ,302A
,332A ,333A ,335A ,336A
,337A ,338A ,339A ,340A
,344A ,352A ,355A ,356A
,359A ,361A ,366A ,369A
,372A ,373A ,390A ,447A
,454A ,458A ,473A
5090 1689 100259 33
4AFG-
clean
99, 151, 152, 153, 154,
155, 191, 192, 193, 197,
198, 199, 200, 275, 277,
278, 326, 329, 337, 338,
339, 386
25A ,100A ,152A ,153A
,154A ,155A ,156A ,194A
,198A ,199A ,201A ,41B
,64B ,66B ,86B ,88B ,115B
,116B ,118B ,120B ,126B
,128B ,165B ,175B
1746 717 63564 22
4B5D-
clean
101, 152, 153, 154, 155,
193, 200, 276, 296, 298,
326, 327, 328, 330, 336,
337, 338
98A ,100A ,102A ,152A
,153A ,154A ,155A ,156A
,194A ,198A ,199A ,201A
,203A ,41B ,64B ,66B ,68B
,86B ,88B ,115B ,116B
,117B ,118B ,120B ,126B
,127B ,128B ,165B ,174B
,175B
3738 761 62034 17
2QRY-
clean
9, 10, 11, 65, 103, 107,
138, 144, 179, 180, 183,
196, 197, 199, 200, 203,
204, 225, 227, 261, 262,
263
27A ,29A ,30A ,59A ,83A
,84A ,120A ,121A ,125A
,128A ,156A ,161A ,162A
,197A ,198A ,201A ,205A
,213A ,214A ,215A ,217A
,218A ,221A ,222A ,243A
,245A ,275A ,279A ,280A
,281A
827 395 58642 22
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Table 2.9: Forward Design Complexes Design Details. Statistics for complementary rotamers gen-
erated and applied to forward design of complexes generated with RosettaMatch for application
ligands. Match scaffold PDB ID, scaffold description, complex designable positions in Rosetta
numbering, ligand chemical component identified, and constraint file that yielded the match are
provided. We also report the number of designable positions as well as the number of com-
plementary rotamers generated, accepted (i.e. passed Rosetta energy and RMSD filters, see
Methods), and applied to design for each benchmark binding site. Only the best 50 rotamers per
residue type per position were applied top design.
Design Scaffold
(PDB ID:
Chain)
Scaffold Description Ligand Binding Site Defini-
tion
DesignablePositions
(Rosetta numbering)
Total
rotamers,
accepted
Total
rotamers,
applied
Total
rotamers,
gener-
ated
Designable
positions,
count
ATZ_1TP6 1TP6:A 1.5 A Crystal Structure
of a NTF-2 Like Pro-
tein of Unknown Func-
tion PA1314 from Pseu-
domonas aeruginosa
ATZ ATZ_0022-
iter_0-fuzz_0-
1_228_1014_2314
7, 8, 10, 12, 15, 16,
17, 30, 31, 34, 40, 42,
48, 53, 57, 64, 67, 69,
71, 88, 90, 92, 99,
101, 103, 105, 117,
120, 122
1414 437 73121 29
ATZ_1Q40 1Q40:A Crystal structure of the
C. albicans Mtr2-Mex67
M domain complex
ATZ ATZ_0018-
iter_0-fuzz_0-
1_655_1670_2136
14, 15, 42, 48, 49, 50,
51, 67, 70, 77, 79,
103, 105, 133, 135,
136, 137, 138, 155,
156, 157, 158, 159
2715 727 103619 23
DOG_3ER7 3ER7:B Crystal structure of
NTF2-like protein of
unknown function
(YP_001812677.1) from
EXIGUOBACTERIUM
SP. 255-15 at 1.50 A
resolution
DOG DOG_0001-
iter_0-fuzz_0-
1_288_1136_2530
6, 7, 10, 11, 14, 23,
35, 54, 57, 61, 62,
63, 64, 67, 78, 79, 80,
81, 82, 92, 94, 95, 98,
111, 113, 116
10809 2592 165516 26
IBP_1JVX 1JVX:A Maltodextrin-binding
protein variant
D207C/A301GS/P316C
cross-linked in crystal
IBP IBP_0007-
iter_0-fuzz_0-
1_759_1061_2710
11, 14, 15, 42, 43, 44,
45, 61, 62, 63, 65, 66,
111, 113, 153, 156,
210, 230, 258, 262,
331, 338, 341, 345
85 85 84936 24
IBP_1TUH 1TUH:A Structure of Bal32a from
a Soil-Derived Mobile
Gene Cassette
IBP IBP_0019-
iter_0-fuzz_0-
1_895_2639_2948
14, 17, 25, 35, 36,
37, 41, 43, 44, 47, 53,
56, 57, 59, 63, 68, 70,
87, 98, 100, 106, 117,
118, 119, 120, 126,
127, 130
1025 418 98950 28
IBP_3ECF 3ECF:A Crystal structure of
an ntf2-like protein
(ava_4193) from an-
abaena variabilis atcc
29413 at 1.90 A resolu-
tion
IBP IBP_0004-
iter_0-fuzz_0-
1_823_1135_2552
8, 9, 11, 13, 15, 16,
21, 23, 24, 26, 30,
41, 44, 47, 48, 50, 52,
55, 61, 77, 79, 91, 93,
100, 103
3753 1248 120051 25
IM4_1JKG 1JKG:A Structural basis for the
recognition of a nucleo-
porin FG-repeat by the
NTF2-like domain of
TAP-p15 mRNA nuclear
export factor
IM4 IM4_0007-
iter_0-fuzz_0-
1_794_1164_1278
23, 24, 26, 28, 31, 34,
44, 46, 47, 51, 57, 60,
61, 62, 63, 64, 66, 67,
69, 71, 94, 100, 108,
110, 130, 134
3444 767 100199 26
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2.9 Continued
Design Scaffold
(PDB ID:
Chain)
Scaffold Description Ligand Binding Site Defini-
tion
DesignablePositions
(Rosetta numbering)
Total
rotamers,
accepted
Total
rotamers,
applied
Total
rotamers,
gener-
ated
Designable
positions,
count
IM4_1Z1S 1Z1S:A Crystal Structure of
Putative Isomerase
PA3332 from Pseu-
domonas aeruginosa
IM4 IM4_0017-
iter_0-fuzz_0-
1_742_1081_1151
17, 26, 29, 39, 58, 62,
65, 68, 69, 70, 71, 97,
104, 106, 108, 122,
126, 130, 131, 134
412 117 51352 20
IM4_3EMM 3EMM:A X-ray structure of pro-
tein from Arabidopsis
thaliana AT1G79260
with Bound Heme
IM4 IM4_0018-
iter_0-fuzz_0-
1_1192_1270_1360
25, 35, 51, 53, 63, 81,
83, 85, 87, 89, 91,
104, 106, 109, 112,
115, 118, 119, 120,
121, 131, 132, 134,
135, 137, 142, 145,
148
2302 737 88738 28
IM4_3GZB 3GZB:A Crystal structure of
putative SnoaL-like
polyketide cyclase
(YP_001182657.1) from
Shewanella putrefa-
ciens CN-32 at 1.44 A
resolution
IM4 IM4_0002-
iter_0-fuzz_0-
1_1083_1296_1408
29, 30, 32, 34, 35, 36,
38, 41, 44, 53, 66, 67,
69, 70, 73, 74, 77, 79,
80, 82, 100, 102, 124,
126, 135, 140, 142
816 213 76121 27
LFN_2FNC 2FNC:A Thermotoga maritima
maltotriose binding
protein bound with
maltotriose.
LFN LFN_0001-
iter_0-fuzz_0-
1_2065_2410_2917
7, 8, 9, 10, 34, 35, 39,
57, 59, 106, 148, 151,
154, 208, 225, 227,
229, 261, 296
2192 598 40354 19
LFN_2OWP 2OWP:A Crystal structure of a
cystatin-like fold pro-
tein (bxe_b1374) from
burkholderia xenovo-
rans lb400 at 2.00 A
resolution
LFN LFN_0001-
iter_0-fuzz_0-
1_1291_1909_2515
17, 20, 21, 23, 25, 32,
44, 47, 61, 67, 73, 76,
90, 92, 94, 103, 105,
107, 118, 121, 125
2086 547 49014 21
NPS_2RCD 2RCD:A CRYSTAL STRUCTURE
OF A PROTEIN WITH
UNKNOWN FUNCTION
FROM DUF3225 FAM-
ILY (ECA3500) FROM
PECTOBACTERIUM
ATROSEPTICUM
SCRI1043 AT 2.32
A RESOLUTION
NPS NPS_0005-
iter_0-fuzz_0-
1_140_1081_2929
20, 21, 23, 24, 26,
28, 30, 32, 35, 38, 39,
47, 50, 52, 54, 60, 61,
63, 64, 65, 67, 69, 72,
74, 95, 106, 108, 110,
119, 122
6517 1869 130983 30
NPS_3GZR 3GZR:A CRYSTAL STRUCTURE
OF AN UNCHARAC-
TERIZED PROTEIN
WITH A CYSTATIN-
LIKE FOLD (CC_2572)
FROM CAULOBACTER
VIBRIOIDES AT 1.40 A
RESOLUTION
NPS NPS_0005-
iter_0-fuzz_0-
1_47_259_1081
14, 15, 18, 21, 26, 36,
39, 40, 42, 44, 50, 53,
54, 56, 57, 58, 60, 61,
67, 88, 90, 95, 101,
106, 108, 126, 128
3974 1142 106224 27
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2.6.2 Figures
Figure 2.8: Profile similarity without >0.9 positions removed. Profile similarities as depicted in
Figure 2.4 panel B, except profile similarities for all designable positions are included.
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2.6.3 Files
S1 Appendix. Plots for all design metrics measured during forward design.
Plots for all design metrics measured during forward design. Design metric distributions measured
for 5000 forward design trajectories of selected matches listed in Table 2.9. Existing Rosetta fil-
ters were applied to calculate binding strain (bindingstrain), interaction energy between the protein
and ligand (residueie), packing statistics (Packstat), shape complementarity between the protein
and ligand (shapecomplementarity), packing with RosettaHoles (holes), and the number of buried
unsatisfied hydrogen bond donors/acceptors (heavyburiedunsats) for each design. Ligand sol-
vent accessible surface area in Å
2
(ligand_sasa), number of hydrogen bonds made between the
protein and ligand (hbond), and number of complementary rotamers incorporated during design
(incorporated_specialrot) were also calculated.
S2 Appendix. Sequence Logos for binding site benchmark complexes at various spe-
cial_rot bonuses.
Sequence logos generated for designable positions in existing complexes listed in S6 Table for
various special_rot bonuses, where each logo represents 5000 design trajectories. A special_rot
bonus of 0 indicates that complementary rotamers were added to the Packer, but received no
score term bias. "Control" sequence logo was generated using the unmodified Packer. "Native"
sequence logo shows the "correct" residue identity found in the native protein-ligand complex.
Sequence logo positions are in Rosetta numbering.
S1 File. PDBs for binding site recovery benchmark.
PDB files for the protein-ligand complexes used for the binding site sequence recovery benchmark.
Files have been cleaned and renumbered for compatibility with Rosetta, where position numbering
corresponds to column "Designable_positions" in Table 2.8.
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S2 File. Match constraints for existing complexes in match comparison.
RosettaMatch constraints (.cst) generated for existing complexes in the PDB for ligands in the
Match comparison benchmark. Constraints consist of the three lowest-energy contacts in the
binding site for the given complex in terms of the two-body Rosetta energies used to assemble
contact pools (fa_rep, fa_atr, fa_elec, hbond_sc, fa_sol) and the hbond_bb_sc term to account for
binding site backbone contacts with the ligand. Existing protein-ligand complexes were relaxed
with the Rosetta FastRelax protocol with the full REF2015 energy function and starting coordinate
constraints before determining constraint contacts.
S3 File. Top5000 RosettaMatch constraints for ligands in match comparison.
RosettaMatch constraints (.cst) generated for the 5000 lowest-energy composite binding site so-
lutions found for application ligands listed in Table 2.4 and applied in the Match comparison
benchmark.
S4 File. Composite binding site definition, RosettaMatch constraint file, and PDBs for
matches carried forward through design.
PDB files for matches that were selected for forward design, the RosettaMatch constraint files
(.cst) that yielded the match, and corresponding source composite binding site definition (.pdb)
that was used to generate the RosettaMatch constraint file.
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Chapter 3
Future Work
While our computational benchmarks demonstrate the viability of these methods in improving
quality metrics pertinent to binding site design, validation ultimately requires design and testing
binders in an experimental setting. We outline two approaches for validating designs generated
using the methods in this work. The first strategy involves designing binders for the compound
DFHBI as in Dou et al.1 and screening for binding function in Escherichia coli with a fluorescent
output. DFHBI is a GFP chromophore analog that is non-toxic, cell-permeable, and fluoresces
upon binding when its internal degrees of freedom are constrained to a planar syn-conformation.2
In addition, this compound is the chromophore for the Spinach aptamer that can be applied as a
positive control. The second strategy involves designing chemically-induced dimerization systems
for ligands of interest as our lab has previously demonstrated.3
Despite the importance of water in mediating interactions within ligand binding sites, the meth-
ods outlined in this work fail to recognize and incorporate waters as placing functional waters is a
complex and ongoing research topic.4,5,6 However, once these interactions are defined, it should
be relatively straightforward to define Rosetta ResidueTypes that incorporate a residue-water in-
teraction for application in composite binding sites and design with complementary rotamers.
Another interaction type not considered in this work was protein backbone contacts with the
ligand. Backbone contacts were excluded from solutions for composite binding sites since an en-
tire residue was included in the solution, and therefore sidechains of residues that contributed to
a backbone-ligand interaction sterically occluded otherwise viable sidechain and backbone con-
tacts with the ligand. This was still an issue with sidechain interactions with the ligand, but the
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backbone is much smaller than the average sidechain considered for composite binding site solu-
tions. Casting contact pool residues as virtual VariantTypes might provide a solution for this issue,
where virtual atoms in Rosetta are not considered during scoring. Since we only care about the
protein-ligand interactions and potential sidechain/backbone packing in composite binding sites,
defining contact pool residues with virtual backbones/sidechains during simulated annealing could
potentially resolve this issue.
It would be extremely interesting to apply composite binding sites in other productive contexts.
In this work, we only generated composite binding sites composed of three residues. However, it
is trivial to expand composite binding sites to an arbitrary number of residues. Composite bind-
ing sites of arbitrary size could serve as a starting point to design entire functional proteins from
the inside-out. Adoption of a high-throughput matching algorithm7 should enable screening of
a greater number of more complex composite binding sites against larger scaffold libraries, ulti-
mately permitting application of more stringent quality filters during this step. If only a subset of
residues in a composite binding site are matched into a scaffold, loop modeling methods such
as kinematic closure,8 pull-into-place (an iterative modeling protocol that makes use of kinematic
closure to precisely position functional residues on loops), or machine learning methods could be
applied to build out a protein to accommodate the remaining composite binding site residues.
Finally, there are several improvements to software infrastructure that would expedite adoption
and use of this method. There are several steps in the protocol, such as assembly of fragment
contact pools, that would benefit from parallelization. At the moment, most processes are per-
formed in series and do not benefit from additional available computing resources. Specifically,
adapting this work to parallelization on cloud or highly-parallel computing resources would facilitate
adoption by academic and industry researchers alike.
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Chapter 4
Conclusion
The methods outlined in this work provide scientists with an expanded repertoire of computational
tools to generate and design binding sites for arbitrary small molecules of interest. First, we re-
move the requirement that a complex for a target molecule must exist in the PDB to create a
binding site definition: composite binding sites instead draw from protein-fragment interactions in
the PDB for fragments that compose the target molecule to generate hundreds of thousands of
composite binding sites de novo. Second, we augment Rosetta’s design machinery with observed
protein-fragment interactions and bias incorporation of these interactions during design to com-
pensate for shortcomings in Rosetta’s energy function when scoring protein-ligand interactions.
Finally, we demonstrate that the combination of the methods introduced in this work result in de-
signed binders with improved metrics that are indicative of design success. While there are several
potential avenues for building upon this work, we have outlined several new strategies that can be
immediately applied to design proteins that create novel protein-ligand interfaces and perform new
functions. These methods can be applied beyond straightforward ligand binding and help inform
design efforts for enzyme design and other protein sensing actuators.
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